Zepteon's Unattributed Round

Zepteon raised a round of funding on April 16, 2015.

Zepteon has developed an antibody development and manufacturing technology that enables biopharmaceutical companies to evaluate and tune their drug potency. This is accomplished by separating high pot…

Articles about Zepteon's Unattributed Round: